Primary pigmentary dispersion is seen predominantly in young myopic males and is often associated with open-angle glaucoma. Recent pathological studies'2 have shown fragmentation of the neuroectodermal pigment of the iris and hyperplasia of the dilator muscle fibres. Mechanical rubbing of the pigment epithelium against bundles of radially disposed zonular fibres may be a factor in causing a release of pigment.3 A mesodermal defect in the angle has been postulated to explain some cases of glaucoma in which pigment release is minimal. In other patients there appears to be a direct relationship between the degree of pigment dispersion and the presence of glaucoma.
The long-term behaviour of the pigment in pigmentary dispersion has not been studied in detail. It is possible the pigment dispersion occurs steadily over a lifetime, or the release could be selflimiting. A reduction of pigment in the angle has been reported in 1 patient over some time,4 and in another an improvement in intraocular pressure occurred. glaucoma was made when an individual had an intraocular pressure over 30 mmHg, and over half this group had glaucomatous cupping and field loss. Of 20 males and 7 females with glaucoma, cupping and field loss were found in 15. The role of pigment in the production of glaucoma was investigated by comparing the degree of pigment dispersion in both eyes in patients with unilateral glaucoma. In 9 patients with unilateral glaucoma there was a definite increase in the severity of the pigment dispersion in the eye with glaucoma. In 6 patients a difference could not be seen clearly. In no patient was the pigment dispersion less in the eye with glaucoma.
Results
A change in pigment dispersion with time was assessed by comparing the findings at the initial examination with those of the most recent follow-up. The great majority of patients who were followed up for 5 years showed no change. Between 5 and 10 years 3 of 8 patients reviewed showed a reduction in pigment and after 10 years 5 of 7 patients showed a reduction. Only 1 patient showed an increase in Table 2 Changes in pigment dispersion The patients with glaucoma were evenly divided between those with intraocular pressure elevation alone and those with cupping and field loss. There was a significant increase in the severity of pigmentary dispersion in the involved eye of the majority of patients with uniocular glaucoma, which suggests that the pigment is a significant factor in the development of glaucoma. Another possibility is that the excessive pigment dispersion in the eyes with glaucoma reflects the presence of other factors responsible for glaucoma but is not itself the primary cause. Since in 6 of the patients with uniocular glaucoma the pigment dispersion appeared to be similar in both eyes, there must have been some additional factor responsible.
The presence of pigment represents a balance between the release of fresh pigment and the destruction of old pigment. The long-term follow-up of these patients indicates a significant reduction in the extent of pigmentary dispersion after a period of 10 years. This suggests a gradual reduction in the production of fresh pigment or, less likely, an increased rate of destruction. Pigment which has been incorporated into endothelial cells (for example, after a traumatic pigment dispersion) is often very slow to disappear and may remain visible long after its active release has stopped. It is possible, therefore, that primary pigment dispersion takes place over a relatively short period even though it can still be seen many years later. Only 1 patient showed an increase in pigment, and this developed over a 5-year period, after the diagnosis was made. For all the other patients it appeared that the bulk of pigment dispersion had taken place by the time the condition was identified.
Haloes after exercise are associated with a heavy release of pigment and are an indication of active dispersion. These symptoms occur early in the course and stop after several years. Pigment circulating in the anterior chamber, and a marked release after pupil dilatation, are additional signs of active pigment dispersion, which gradually disappear as the patient grows older. It is difficult to be precise, but the evidence suggests that most pigment dispersion takes place over a period of about 5 years.
Five of 8 patients on treatment for glaucoma failed to show a pressure increase when the treatment was stopped and 3 of these patients showed a decrease in pigment dispersion. This is a further indication that for some people pigment is responsible for glaucoma, and for many of these individuals both the pigment release and the glaucoma are self-limiting. One patient who had a reduction in corneal pigment showed a persistent rise in pressure when treatment was stopped. It is possible that factors other than pigment were responsible for the glaucoma, or it may be that pigment remaining in the angle was sufficient to produce an obstruction to outflow. Patients who show a reduction in corneal pigment still have excessive pigmentation of the trabecular meshwork on gonioscopy.
The management of patients with pigmentary dispersion needs to be reassessed in view of the evidence that this condition is self-limiting. Patients seen for the first time with no evidence of glaucoma should be examined at regular intervals for at least 5 years because of the possibility that active pigment dispersion is still taking place which might cause a rise in pressure. The great majority of patients do not show evidence of a progressive increase in pigment dispersion, and only 3 had a rise in pressure develop within 5 years of making the diagnosis. After 10 years there is increasing evidence of a reduction in pigment dispersion, and no patients showed a rise in pressure after this interval.
Patients who require treatment for glaucoma should be encouraged to persist with medical therapy because of the chances of remission as the pigment dispersion slows down. This is often possible with the uniocular and less severe bilateral cases. However, the younger patients who require miotics are usually unable to tolerate the side effects. When medical treatment has been employed for several years and pressure control is satisfactory, medications can be reduced and often stopped altogether. Many of these eyes show a reduction in pigment dispersion.
Conclusion. After a period of several years patients with pigment dispersion syndrome may show a reduction in the amount of dispersed pigment, and glaucoma, if present, may go into remission.
